Biosafety Levels 1-4: A Decision Framework for Diagnostic Laboratories

Diagnostic laboratories handle infectious agents across a wide spectrum of risk, and the containment level required depends on the specific organism, the procedures performed, and the potential for aerosol generation. Biosafety levels 1 through 4 represent escalating combinations of facility design, safety equipment, and work practices that control exposure to biological agents. This article provides a decision framework for selecting the appropriate biosafety level based on risk group classification, planned procedures, and facility capabilities, with emphasis on practical implementation for diagnostic settings.

At a Glance: Risk Group to Biosafety Level Mapping

The World Health Organization Laboratory Biosafety Manual provides the foundational guidance for matching risk groups to biosafety levels. Risk group assignment reflects the pathogen's ability to cause disease in healthy adults, the severity of that disease, the transmissibility, and the availability of effective treatment and prevention measures. The table below summarizes the standard relationship between risk groups and biosafety levels, along with key containment requirements.

The Laboratory Biosafety Manual from the World Health Organization emphasizes that biosafety level selection must be based on a risk assessment that considers the agent, the procedure, and the facility. A diagnostic laboratory performing only serological testing on inactivated samples may require a lower biosafety level than a research laboratory propagating the same organism in large quantities.

Core Principles of Biosafety Level Selection

Risk Group Classification as the Starting Point

Risk group classification provides the initial framework for biosafety decisions. The World Health Organization groups pathogens into four risk classes based on their effect on healthy adults, the potential for spread in the community, and the availability of effective prophylaxis and treatment. The Laboratory Quality Management System Handbook from the World Health Organization notes that laboratories must integrate biosafety considerations into their quality management systems, ensuring that risk assessments are documented and reviewed regularly.

Risk group classification is not static. Evidence can emerge that supports reclassification. For example, recommendations have been made for reclassifying Orientia species from risk group 3 to risk group 2 based on analysis of laboratory-acquired infections, diagnostic procedures, and available treatments, as described in Biosafety and biosecurity requirements for Orientia spp. diagnosis and research. Diagnostic laboratories should monitor the scientific literature and regulatory updates to ensure their containment levels reflect current evidence.

Procedure-Based Risk Assessment

The same organism can require different containment levels depending on the procedure. Diagnostic activities that involve only inactivated specimens, fixed tissues, or serological testing generally pose lower risks than procedures that propagate live organisms or generate aerosols. The review of Coxiella burnetii biosafety practices illustrates this principle: propagative work with this risk group 3 bacterium requires BSL-3 containment, while diagnostic activities can be conducted at BSL-2 with appropriate practices. This distinction between propagation and diagnosis is a recurring theme in biosafety guidance.

Facility Design and Engineering Controls

Each biosafety level builds on the previous level's requirements. BSL-1 requires basic facilities with handwashing sinks and surfaces that can be cleaned. BSL-2 adds requirements for biological safety cabinets, autoclaves or other decontamination equipment, and restricted access. BSL-3 requires directional airflow, sealed penetrations, and a dedicated area with controlled access. BSL-4 requires either a class III biological safety cabinet line or a positive-pressure suit laboratory within an isolated building or module.

The Laboratory Biosafety Manual provides detailed specifications for each level. Laboratories should verify that their facilities meet the engineering requirements before conducting work at a given biosafety level. Retrofitting an existing facility to a higher biosafety level is often more expensive and complex than designing for the required level from the start.

Decision Framework for Diagnostic Laboratories

Step 1: Identify the Agent and Confirm Risk Group

Begin by identifying the infectious agent or agents that may be present in the specimens your laboratory receives. Consult the World Health Organization risk group classifications and your national regulatory requirements. Document the risk group for each agent in your laboratory's biosafety manual.

Consider whether the agent has unusual characteristics that affect risk. Some pathogens have a very low infectious dose, high environmental resilience, or the potential for aerosol transmission, which may warrant enhanced containment beyond what the risk group alone suggests. The Coxiella burnetii review notes that this bacterium's low infectious dose and environmental persistence create significant biosafety challenges even within the appropriate containment level.

Step 2: Define the Scope of Work

Determine whether your laboratory will perform diagnostic testing only, which typically involves handling clinical specimens and possibly inactivating or isolating the agent, or whether you will also conduct propagative work, such as culturing the organism in large quantities. The scope of work directly affects the required biosafety level.

For example, the safety procedures for West Nile virus work in BSL-3 facilities describe the enhanced precautions needed when working with a risk group 3 arbovirus that can be transmitted through aerosols and needlesticks. Diagnostic laboratories that handle West Nile virus specimens for serological testing may operate at BSL-2, but laboratories that propagate the virus require BSL-3.

Step 3: Evaluate Aerosol-Generating Procedures

Identify all procedures that can generate aerosols, including centrifugation, vortexing, sonication, opening lyophilized cultures, and homogenization. Procedures that generate aerosols require primary containment, typically a biological safety cabinet, regardless of the biosafety level.

The Laboratory Quality Management System Handbook emphasizes that standard operating procedures must specify when biological safety cabinets are required and how they should be used. Laboratories should review each procedure to determine whether aerosol generation is possible and whether the procedure can be modified to reduce aerosol production.

Step 4: Assess Personnel Competency and Training

Biosafety level requirements include personnel training and competency assessment. All laboratory staff must receive training on the specific hazards associated with the agents they handle, the proper use of containment equipment, and emergency procedures. The biosafety assessment framework for BSL-3 laboratories in India includes staff training and competency as a core assessment domain, recognizing that human error is a leading cause of laboratory-acquired infections.

Document training for each staff member, including the date of initial training, refresher training, and competency assessments. Retain these records for review during internal audits and regulatory inspections.

Step 5: Document the Risk Assessment and Decision

Record the risk assessment that supports your biosafety level selection. Include the agent identification, risk group classification, scope of work, procedures performed, engineering controls available, and the rationale for the chosen biosafety level. Review and update this documentation whenever there is a change in the agent, procedures, facility, or personnel.

The multi-method integrated weighting framework for biosafety risk assessment demonstrates that structured, reproducible risk assessment methods improve the consistency and interpretability of biosafety decisions. While diagnostic laboratories may not need the full analytical complexity of research-grade risk assessment tools, the principle of systematic, documented evaluation applies.

Biosafety Level 1: Basic Containment

Applicable Agents and Procedures

BSL-1 is appropriate for work with well-characterized agents that are unlikely to cause disease in healthy adults. These include non-pathogenic strains of Escherichia coli, Bacillus subtilis, and other organisms that do not pose a significant threat to laboratory workers or the environment. Diagnostic laboratories may use BSL-1 for environmental samples, quality control organisms, and teaching laboratories.

Facility and Practice Requirements

BSL-1 laboratories require a handwashing sink, surfaces that can be easily cleaned and decontaminated, and a door that can be closed to restrict access when needed. Work can be conducted on an open bench, but standard microbiological practices apply, including no eating, drinking, or applying cosmetics in the laboratory, and handwashing after handling viable materials.

Limitations and Escalation Criteria

BSL-1 is not appropriate for any work with human pathogens or with specimens that may contain human pathogens. If a laboratory receives clinical specimens that may contain risk group 2 or higher agents, the laboratory must operate at least at BSL-2. Escalate to BSL-2 when any of the following conditions apply: the laboratory receives clinical specimens, the agent is known or suspected to cause human disease, or the procedure involves manipulation of viable organisms that are not well-characterized as non-pathogenic.

Biosafety Level 2: Containment for Moderate-Risk Agents

Applicable Agents and Procedures

BSL-2 is the most common biosafety level for diagnostic laboratories. It is appropriate for work with risk group 2 agents, which cause human disease but for which effective treatment and prevention measures exist. Examples include Staphylococcus aureus, Salmonella species, and many respiratory viruses. The dengue virus biosafety analysis highlights that dengue virus, a risk group 2 pathogen, is handled at BSL-2 in many settings, though global standards vary considerably.

Facility and Practice Requirements

BSL-2 laboratories include all BSL-1 requirements plus restricted access during work, a biological safety cabinet for procedures that may generate aerosols, and an autoclave or alternative method for decontaminating infectious waste. Personnel must receive training on the specific agents handled and must demonstrate competency before working independently.

The Laboratory Biosafety Manual specifies that BSL-2 laboratories should have a sink for handwashing, an eyewash station, and surfaces that are resistant to chemicals and easy to clean. The laboratory should be designed so that it can be easily cleaned and decontaminated.

Diagnostic Testing at BSL-2

Many diagnostic procedures for risk group 3 agents can be conducted at BSL-2 when the work involves only inactivated specimens or when the diagnostic procedure does not propagate the organism. The Coxiella burnetii review notes that BSL-2 standards are acceptable for diagnostic activities with this risk group 3 pathogen, while propagative work requires BSL-3. Similarly, the Orientia reclassification recommendation argues that diagnostic work with these organisms can be safely conducted at BSL-2.

When performing diagnostic testing at BSL-2 for agents classified in risk group 3, document the specific procedures that justify the lower containment level. These procedures typically include serological testing, molecular testing on inactivated samples, and microscopy on fixed specimens. Any procedure that involves culturing the organism or manipulating viable specimens in ways that could generate aerosols requires BSL-3.

Limitations and Escalation Criteria

Escalate from BSL-2 to BSL-3 when any of the following conditions apply: the laboratory begins propagative work with risk group 3 agents, the agent has a very low infectious dose or high environmental resilience, the procedure generates significant aerosols that cannot be contained in a biological safety cabinet, or a laboratory-acquired infection occurs despite BSL-2 practices.

Biosafety Level 3: High Containment

Applicable Agents and Procedures

BSL-3 is required for work with risk group 3 agents, which cause serious or potentially lethal human disease through inhalation. Examples include Mycobacterium tuberculosis, Coxiella burnetii, West Nile virus, and SARS-CoV-2. The laboratory biosafety measures for SARS-CoV-2 describe the classification of this virus as a risk group 3 biological agent and the corresponding containment requirements.

Facility and Practice Requirements

BSL-3 laboratories require all BSL-2 features plus a controlled access zone with two self-closing doors, directional airflow that draws air into the laboratory from clean areas, and a ventilation system that exhausts air through HEPA filtration. All work with viable agents must be conducted in a biological safety cabinet or other primary containment device.

Personnel working in BSL-3 laboratories require additional training, including donning and doffing of personal protective equipment, emergency procedures, and recognition of containment failures. The biosafety assessment framework for BSL-3 laboratories includes emergency preparedness and response as a core assessment domain, reflecting the importance of readiness for incidents.

Diagnostic Testing at BSL-3

Diagnostic laboratories that handle specimens potentially containing risk group 3 agents must have BSL-3 capabilities for procedures that involve viable organisms. This includes specimen processing for culture, antimicrobial susceptibility testing, and any procedure that could generate infectious aerosols. The safety procedures for West Nile virus work describe the specific practices required in BSL-3 facilities, including the use of biological safety cabinets for all manipulations of viable virus.

Limitations and Escalation Criteria

Escalate from BSL-3 to BSL-4 when working with risk group 4 agents, which cause severe human disease with no effective treatment or prevention. Also escalate when the agent has demonstrated the potential for laboratory-acquired infection despite BSL-3 containment, or when the procedure requires manipulation of large quantities of agent that could overwhelm containment systems.

Biosafety Level 4: Maximum Containment

Applicable Agents and Procedures

BSL-4 is the highest level of biological containment and is required for work with risk group 4 agents. These include viruses that cause severe, often lethal, human disease with no effective treatment or vaccine. The vaccine candidates against arenavirus infections review notes that several highly pathogenic arenaviruses are classified as risk group 4 agents and must be handled in BSL-4 facilities. Similarly, the filovirus review describes Ebola and Marburg viruses as risk group 4 pathogens that require the highest level of specialized protective laboratories.

Facility and Practice Requirements

BSL-4 laboratories require either a class III biological safety cabinet line or a positive-pressure suit laboratory within an isolated building or module. The facility must have dedicated supply and exhaust ventilation with redundant HEPA filtration, a double-door autoclave for waste decontamination, and a chemical dunk tank or fumigation chamber for materials that cannot be autoclaved.

All waste, including liquid effluent, must be decontaminated before leaving the facility. Personnel must shower before exiting the laboratory and must follow strict protocols for donning and doffing protective equipment.

Diagnostic Considerations

Most diagnostic laboratories will never need BSL-4 containment. Specimens suspected of containing risk group 4 agents should be referred to a national reference laboratory or a specialized maximum containment facility. The Laboratory Biosafety Manual provides guidance on the referral process and the packaging and transport requirements for high-risk specimens.

Limitations and Escalation Criteria

BSL-4 is appropriate only for laboratories with the specialized facility design, trained personnel, and operational protocols required for maximum containment. If a diagnostic laboratory receives specimens suspected of containing risk group 4 agents, the laboratory should not open the specimen. Instead, the laboratory should follow its emergency protocol for referral to an appropriate facility.

Practical Implementation and Assessment Steps

Conduct a Gap Analysis

Compare your current facility, equipment, and practices against the requirements for the biosafety level you have determined is appropriate. Document the gaps and develop a plan to address them. The biosafety assessment framework for BSL-3 laboratories provides a scoring checklist that assesses staff training, sample handling and transportation, sample processing and testing procedures, data management and reporting, biomedical waste management, emergency preparedness and response, and general biosafety. This framework can be adapted for use in any diagnostic laboratory.

Verify Engineering Controls

Test biological safety cabinets annually or after any maintenance or relocation. Verify that the cabinet provides adequate airflow and HEPA filtration. For BSL-3 laboratories, verify directional airflow daily using a visual indicator such as a smoke test or a pressure gauge. Document all verification results.

Validate Decontamination Procedures

Ensure that autoclaves are tested regularly using biological indicators that confirm the destruction of spores. Verify that chemical disinfectants are prepared at the correct concentration and have not expired. The Lean Six Sigma study on sharps waste management identified recurrent nonconformities in labeling, documentation, and internal transport routes in emergency care units, highlighting the importance of systematic waste management practices.

Train and Assess Personnel

Provide initial training on biosafety practices, the specific agents handled, and emergency procedures. Assess competency through observation and written examination. Provide refresher training at least annually and after any significant change in procedures or agents.

Review and Update the Risk Assessment

Review the risk assessment at least annually and after any of the following events: a change in the agents handled, a change in procedures, a laboratory-acquired infection, a containment failure, or new scientific evidence about the agent's pathogenicity or transmissibility. The dengue virus biosafety analysis underscores the need for harmonized, evidence-based guidelines and highlights how inconsistencies in risk group classifications across regions complicate containment decisions.

Records and Measurements

Required Documentation

Maintain the following records for each biosafety level decision and for ongoing operations:

• Risk assessment documentation, including agent identification, risk group classification, and rationale for the chosen biosafety level
• Standard operating procedures for all laboratory processes
• Training records for all personnel, including initial and refresher training dates
• Biological safety cabinet certification and maintenance records
• Autoclave validation and maintenance records
• Incident reports for any exposures, spills, or containment failures
• Medical surveillance records for personnel working at BSL-3 or higher

The Laboratory Quality Management System Handbook emphasizes that documentation is a core component of laboratory quality management and that records must be accurate, complete, and retrievable.

Performance Indicators

Track the following indicators to assess the effectiveness of your biosafety program:

• Number of laboratory-acquired infections or exposures per year
• Number of containment failures or near misses
• Percentage of staff with current training and competency assessments
• Percentage of biological safety cabinets with current certification
• Autoclave biological indicator test results
• Compliance with handwashing and personal protective equipment requirements during audits

Audit and Review Schedule

Conduct internal audits of biosafety practices at least annually. Use a standardized checklist that covers facility, equipment, practices, training, and documentation. The biosafety assessment framework for BSL-3 laboratories was developed to periodically assess laboratory performance and can serve as a model for audit tools in other settings.

Common Failure Patterns

Misclassification of Risk Group

Laboratories sometimes underestimate the risk group of an agent, leading to inadequate containment. This can occur when the laboratory relies on outdated classifications, when the agent has been reclassified based on new evidence, or when the laboratory confuses the risk group with the biosafety level. The Orientia reclassification recommendation demonstrates that risk group classifications can change as evidence accumulates, and laboratories must stay current.

Inconsistent Application of Practices

Even when the correct biosafety level is selected, inconsistent application of practices undermines containment. Common failures include not using a biological safety cabinet for aerosol-generating procedures, improper donning or doffing of personal protective equipment, and failure to decontaminate work surfaces after each procedure. The Lean Six Sigma study found that managerial and behavioral gaps were the primary causes of nonconformities in waste management, emphasizing that training and supervision are as important as facility design.

Inadequate Training and Competency Assessment

Laboratories sometimes provide initial training but fail to assess competency or provide refresher training. This can lead to skill degradation and unsafe practices. The biosafety assessment framework for BSL-3 laboratories includes staff training and competency as a core assessment domain, recognizing that human error is a leading cause of laboratory-acquired infections.

Failure to Update Risk Assessments

Risk assessments that are not reviewed and updated become outdated. New evidence about an agent's pathogenicity, transmissibility, or environmental stability may warrant a change in containment level. The Coxiella burnetii review notes that gaps remain in disinfection efficacy data and consistent application of biosafety measures, highlighting the need for ongoing review and adaptation.

Inadequate Emergency Preparedness

Laboratories sometimes lack clear procedures for spills, exposures, and containment failures. This can lead to delayed or inappropriate responses that increase the risk of infection. The biosafety assessment framework for BSL-3 laboratories includes emergency preparedness and response as a core assessment domain, and laboratories should develop and practice emergency procedures regularly.

Welfare and Safety Context

Laboratory-Acquired Infections

Laboratory-acquired infections are a persistent risk in diagnostic laboratories. The Coxiella burnetii review notes that this bacterium has been a leading cause of laboratory-acquired infections, underscoring the importance of implementing risk-based biosafety frameworks. Laboratories should track exposures and infections and use this data to improve their biosafety programs.

Occupational Health Programs

Personnel working at BSL-3 or higher should participate in a medical surveillance program that includes baseline health assessment, vaccination where available, and post-exposure follow-up. The Laboratory Biosafety Manual provides guidance on occupational health programs for laboratory personnel.

Global Variability in Standards

Biosafety standards vary across countries and regions, which can complicate decisions for laboratories that receive specimens from multiple jurisdictions. The dengue virus biosafety analysis found substantial variability in global standards for biosafety levels and risk group classifications, and the authors called for harmonized, evidence-based guidelines. Diagnostic laboratories should be aware of these inconsistencies and should follow the most stringent applicable standard when in doubt.

Biosecurity Considerations

Biosafety and biosecurity are related but distinct concepts. Biosafety focuses on protecting laboratory workers and the environment from accidental exposure, while biosecurity focuses on preventing intentional misuse of pathogens. The nucleic acid synthesis screening policy review discusses the importance of layered defense frameworks in which multiple, imperfect but complementary safeguards reduce systemic risk. Diagnostic laboratories should consider both biosafety and biosecurity in their risk assessments.

Professional Escalation Criteria

When to Consult a Biosafety Officer

Consult a biosafety officer or institutional biosafety committee when any of the following conditions apply:

• You are uncertain about the risk group classification of an agent
• You are planning to introduce a new agent or procedure that may require a higher biosafety level
• A laboratory-acquired infection or exposure has occurred
• A containment failure has occurred, such as a biological safety cabinet malfunction or a breach in facility integrity
• You are planning to work with an agent that has unusual characteristics, such as a very low infectious dose or high environmental resilience

When to Refer Specimens to a Higher Containment Facility

Refer specimens to a higher containment facility when any of the following conditions apply:

• The specimen may contain a risk group 4 agent
• The specimen may contain a risk group 3 agent and your laboratory does not have BSL-3 capabilities
• The procedure required for diagnosis involves propagation of an agent that your laboratory is not equipped to contain
• The specimen is from a patient with a suspected infection that has caused laboratory-acquired infections in other settings

When to Suspend Work

Suspend work in the laboratory when any of the following conditions apply:

• A biological safety cabinet fails certification or shows signs of malfunction
• The facility ventilation system fails or directional airflow is compromised
• An autoclave fails biological indicator testing
• A laboratory-acquired infection occurs and the source cannot be identified
• An incident occurs that suggests a systemic failure in biosafety practices

Frequently Asked Questions

What is the difference between a risk group and a biosafety level?

A risk group is a classification of a biological agent based on its ability to cause disease in healthy adults, the severity of that disease, the transmissibility, and the availability of effective treatment and prevention. A biosafety level is a set of containment requirements, including facility design, safety equipment, and work practices, that is selected based on the risk group of the agent and the procedures being performed. The Laboratory Biosafety Manual provides the standard framework for matching risk groups to biosafety levels.

Can diagnostic testing for a risk group 3 agent be performed at BSL-2?

Yes, in some cases. Diagnostic activities that involve only inactivated specimens, serological testing, or molecular testing on inactivated samples may be conducted at BSL-2 for certain risk group 3 agents. The Coxiella burnetii review notes that BSL-2 standards are acceptable for diagnostic activities with this risk group 3 bacterium, while propagative work requires BSL-3. However, any procedure that involves culturing the organism or manipulating viable specimens in ways that could generate aerosols requires BSL-3.

How often should a biological safety cabinet be certified?

Biological safety cabinets should be certified at least annually, after any maintenance or relocation, and after any event that could affect their performance. Certification verifies that the cabinet provides adequate airflow and HEPA filtration. The Laboratory Quality Management System Handbook emphasizes that equipment must be maintained and verified to ensure it performs as intended.

What should a laboratory do if it receives a specimen suspected of containing a risk group 4 agent?

The laboratory should not open the specimen. The laboratory should follow its emergency protocol for referral to an appropriate maximum containment facility. The Laboratory Biosafety Manual provides guidance on the packaging and transport requirements for high-risk specimens.

How does the risk group classification of an agent change over time?

Risk group classifications can change as new evidence emerges about an agent's pathogenicity, transmissibility, or environmental stability. For example, recommendations have been made for reclassifying Orientia species from risk group 3 to risk group 2 based on analysis of laboratory-acquired infections and available treatments, as described in Biosafety and biosecurity requirements for Orientia spp. diagnosis and research. Laboratories should monitor the scientific literature and regulatory updates to ensure their containment levels reflect current evidence.

What training is required for personnel working at BSL-3?

Personnel working at BSL-3 require additional training beyond the basic biosafety training provided at BSL-2. This includes training on the specific hazards associated with the agents handled, proper donning and doffing of personal protective equipment, emergency procedures, and recognition of containment failures. The biosafety assessment framework for BSL-3 laboratories includes staff training and competency as a core assessment domain.

What is the role of a biosafety officer in a diagnostic laboratory?

A biosafety officer provides guidance on risk assessment, biosafety level selection, containment practices, and emergency response. The biosafety officer reviews standard operating procedures, conducts audits, investigates incidents, and ensures that personnel are adequately trained. Diagnostic laboratories should have access to a biosafety officer, either on staff or through an institutional biosafety committee.

How should a laboratory respond to a containment failure?

The laboratory should follow its emergency response plan, which should include procedures for evacuating personnel, containing the spill or release, decontaminating the affected area, and reporting the incident to the appropriate authorities. The biosafety assessment framework for BSL-3 laboratories includes emergency preparedness and response as a core assessment domain, and laboratories should practice emergency procedures regularly to ensure readiness.

Related Diagnostic Guides

• Biosafety Cabinet Types and Selection Guide for Microbiology Laboratories
• Cloud-Based Diagnostic Data Integration for Herd Health Management
• Computational Modeling of Veterinary Virus Spread based on Diagnostic Data
• CRISPR-Cas12a Based Detection of Canine Parvovirus Type 2: A Rapid Point-of-Care Diagnostic
• CRISPR-Cas12a-Based Biosensor for Rapid Detection of African Swine Fever Virus: From Assay Design to Field Deployment

References and Further Reading

• Laboratory Quality Management System Handbook. World Health Organization.
• Laboratory Biosafety Manual. World Health Organization.
• Assay Guidance Manual. National Center for Advancing Translational Sciences.
• Bioanalytical Method Validation Guidance. U.S. Food and Drug Administration.
• NCBI Literature Resources. National Center for Biotechnology Information.
• Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data.. The Lancet. Respiratory medicine, 2014.
• Genetic architecture and risk prediction of gestational diabetes mellitus in Chinese pregnancies.. Nature communications, 2025.
• Vaccine Candidates against Arenavirus Infections.. Vaccines, 2023.
• Emergent Risk Group-4 (RG-4) Filoviruses: A paradox in progress.. Bioinformation, 2023.
• Dengue Virus Biosafety: An Analysis of Evidence, Global Inconsistencies, and Risk Gaps.. Applied biosafety : journal of the American Biological Safety Association, 2025.
• Immune resilience despite inflammatory stress promotes longevity and favorable health outcomes including resistance to infection.. Nature communications, 2023.
• Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial.. Nature communications, 2024.
• Assessing the evidence for effective biosafety risk management in Coxiella burnetii research.. One health (Amsterdam, Netherlands), 2025.
• A multi-method integrated weighting framework for biosafety risk assessment of infectious substances.. 2026.
• In Vitro Phenotypic Screening and MALDI-TOF Identification of Lactic Acid Bacteria Isolated from Feces of Suckling Piglets with Antibacterial Activity.. 2026.
• COVID-19 in Space: Possible Health Risks and Preparedness Guidelines.. 2026.
• Compounding asymmetries in nucleic acid synthesis screening: policy pathways for strengthening global biosecurity governance.. 2026.
• Genetic manipulation technologies for precise cellular control: a comparative review of five approaches.. 2026.
• Lean Six Sigma for Sharps Waste Management and Occupational Biosafety in Emergency Care Units.. 2026.
• A framework for evaluating biosafety and biosecurity in national network of biosafety level-3 laboratories in India: an initiative under national one health mission.. 2025.
• Biosafety risks and mitigation strategies for mosquito infection in Arthropod Containment Level-2 laboratory. China Tropical Medicine, 2023.
• Biosafety and biosecurity requirements for Orientia spp. diagnosis and research: Recommendations for risk-based biocontainment, work practices and the case for reclassification to risk group 2. BMC Infectious Diseases, 2019.
• Safety Procedures to Work with West Nile Virus in Biosafety Level 3 Facilities. Methods in Molecular Biology, 2023.
• Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent. Pathology, 2020.

This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.